| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2639-2644.)
© 1999 American Heart Association, Inc.
Clinical Investigation and Reports |
Treatment of Acute Myocardial Infarction by Primary Coronary Angioplasty or Intravenous Thrombolysis in the "Real World"
One-Year Results From a Nationwide French Survey
From the Department of Cardiology, University Hospital of Nancy-Brabois (N.D., M.A.); Laboratoires Roussel, Paris la Défense (L.V., N.G., S.E.); and ORSMIP, Toulouse (J.F., J.-P.C.), France.
Correspondence to Prof Nicolas Danchin, Service de Cardiologie, CHU Nancy-Brabois, 54511 Vandoeuvre-lès-Nancy, Cedex, France. E-mail n.danchin{at}chu-nancy.fr
Background—Recent randomized trials comparing primary coronary angioplasty and intravenous thrombolysis at the acute stage of myocardial infarction have shown a limited but definite advantage for primary angioplasty. The aim of this study was to document 1-year outcome in patients receiving either thrombolysis or primary angioplasty for acute myocardial infarction in the "real world."
Methods and Results—We used a nationwide prospective registry of all patients admitted for acute myocardial infarction in French intensive care units in November 1995. Of the 721 patients who received reperfusion therapy, 152 were treated with primary angioplasty and 569 received intravenous thrombolysis. The two groups were remarkably similar with respect to all baseline descriptors, except that a higher proportion of patients in the angioplasty group had a history of cerebrovascular accident (10% versus 2%, P<0.01). In-hospital outcome was not different in the 2 groups. One-year survival was 85.5% in the angioplasty group and 89.5% in the thrombolysis group (P=0.18). Multivariate analysis showed that older age, anterior location of infarction, female sex, and history of heart failure were related to 1-year mortality. In patients alive on day 5, the use of primary angioplasty and higher Killip class were additional adverse prognostic indicators.
Conclusions—The results of this large registry of real-world practice indicate no survival benefit for patients treated with primary angioplasty compared with those who received thrombolytic therapy.
Key Words: myocardial infarction • thrombolysis • angioplasty
This article has been cited by other articles:
 |
|
 |
|
  N. Danchin, P. Coste, J. Ferrieres, P.-G. Steg, Y. Cottin, D. Blanchard, L. Belle, B. Ritz, G. Kirkorian, M. Angioi, et al. Comparison of Thrombolysis Followed by Broad Use of Percutaneous Coronary Intervention With Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Acute Myocardial Infarction: Data From the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI) Circulation, July 15, 2008; 118(3): 268 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Stenestrand, J. Lindback, L. Wallentin, and for the RIKS-HIA Registry Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA, October 11, 2006; 296(14): 1749 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P G Steg, J-P Cambou, P Goldstein, E Durand, P Sauval, Z Kadri, D Blanchard, J-M Lablanche, P Gueret, Y Cottin, et al. Bypassing the emergency room reduces delays and mortality in ST elevation myocardial infarction: the USIC 2000 registry Heart, October 1, 2006; 92(10): 1378 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A-A Fassa, P Urban, D Radovanovic, N Duvoisin, J-M Gaspoz, J-C Stauffer, P Erne, and for the AMIS Plus Investigators Trends in reperfusion therapy of ST segment elevation myocardial infarction in Switzerland: six year results from a nationwide registry Heart, July 1, 2005; 91(7): 882 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Danchin, D. Blanchard, P. G. Steg, P. Sauval, G. Hanania, P. Goldstein, J.-P. Cambou, P. Gueret, L. Vaur, Y. Boutalbi, et al. Impact of Prehospital Thrombolysis for Acute Myocardial Infarction on 1-Year Outcome: Results From the French Nationwide USIC 2000 Registry Circulation, October 5, 2004; 110(14): 1909 - 1915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, et al. ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction--executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction) J. Am. Coll. Cardiol., August 4, 2004; 44(3): 671 - 719. [Full Text] [PDF]
|
|
|
|
|
|
E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green, M. Hand, J. S. Hochman, H. M. Krumholz, F. G. Kushner, G. A. Lamas, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation, August 3, 2004; 110(5): 588 - 636. [Full Text] [PDF]
|
|
|
|
|
|
C. Pechlaner, R. Bellmann, A. Yee, A. Gabayan, E. V. Carbajal, and T. Aversano Thrombolytic Therapy vs Angioplasty in Acute Myocardial Infarction JAMA, November 13, 2002; 288(18): 2263 - 2264. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A.K. Gitt, E. Boersma, P.M. Fioretti, M.L. Simoons, and A. Battler A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur. Heart J., August 1, 2002; 23(15): 1190 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Buller and R. G. Carere New advances in the management of acute coronary syndromes: 3. The role of catheter-based procedures Can. Med. Assoc. J., January 1, 2002; 166(1): 51 - 61. [Full Text] [PDF]
|
|
|
|
|
|
P. W. Armstrong New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction Can. Med. Assoc. J., September 1, 2001; 165(6): 791 - 797. [Full Text] [PDF]
|
|
|
|
|
|
O Kamp, W Lepper, J.-L Vanoverschelde, B.C Aeschbacher, D Rovai, P Assayag, P Voci, Y Kloster, A Distante, and C.A Visser Serial evaluation of perfusion defects in patients with a first acute myocardial infarction referred for primary PTCA using intravenous myocardial contrast echocardiography Eur. Heart J., August 2, 2001; 22(16): 1485 - 1495. [Abstract] [PDF]
|
|
|
|
|
|
P. W. Armstrong and D. Collen Fibrinolysis for Acute Myocardial Infarction : Current Status and New Horizons for Pharmacological Reperfusion, Part 2 Circulation, June 19, 2001; 103(24): 2987 - 2992. [Full Text] [PDF]
|
|
|
|
|
|
R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, T. Voigtlander, M. Gottwik, G. Berg, E. Altmann, et al. Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty?: Results from the pooled data of the maximal individual therapy in acute myocardial infarction registry and the myocardial infarction registry J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1827 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. R. Every and K. G. Lehmann The effectiveness of primary PTCA: does patient risk matter? J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1836 - 1838. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Magid, B. N. Calonge, J. S. Rumsfeld, J. G. Canto, P. D. Frederick, N. R. Every, H. V. Barron, and for the National Registry of Myocardial Infarction Relation Between Hospital Primary Angioplasty Volume and Mortality for Patients With Acute MI Treated With Primary Angioplasty vs Thrombolytic Therapy JAMA, December 27, 2000; 284(24): 3131 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Zahn, R. Schiele, S. Schneider, A. K. Gitt, H. Wienbergen, K. Seidl, C. Bossaller, H. J. Buttner, M. Gottwik, E. Altmann, et al. Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis: Results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR) J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2064 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.A.A Fox, D.V Cokkinos, J Deckers, U Keil, A Maggioni, and G Steg The ENACT study: a pan-European survey of acute coronary syndromes Eur. Heart J., September 1, 2000; 21(17): 1440 - 1449. [Abstract] [PDF]
|
|
|
|
|
|
C. P. Cannon, C. M. Gibson, C. T. Lambrew, D. A. Shoultz, D. Levy, W. J. French, J. M. Gore, W. D. Weaver, W. J. Rogers, and A. J. Tiefenbrunn Relationship of Symptom-Onset-to-Balloon Time and Door-to-Balloon Time With Mortality in Patients Undergoing Angioplasty for Acute Myocardial Infarction JAMA, June 14, 2000; 283(22): 2941 - 2947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Berger, N. Danchin, L. Vaur, N. Genes, S. Etienne, M. Angioi, J. Ferrieres, and J.-P. Cambou Treatment of Acute Myocardial Infarction by Primary Coronary Angioplasty or Intravenous Thrombolysis Response Circulation, May 30, 2000; 101 (21): e211 - e212. [Full Text] [PDF]
|
|
|
|
 |
|
 N. M Robinson and A. D Timmis Reperfusion in acute myocardial infarction BMJ, May 20, 2000; 320(7246): 1354 - 1355. [Full Text]
|
|